Tripterygium glycosides for safely controlling disease activity in systemic lupus erythematosus: a systematic review with meta-analysis and trial sequential analysis

Background: Tripterygium glycosides have been used to treat systemic lupus erythematosus (SLE) for a long time, showing the effects of immune regulation. We aimed to evaluate the benefits and risks of Tripterygium Glycosides Tablets (TGT) for patients with SLE. Methods: We searched electronic databa...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yifan, Wang, Liuding, Li, Nannan, Zhou, Caiyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436586/
https://www.ncbi.nlm.nih.gov/pubmed/37601046
http://dx.doi.org/10.3389/fphar.2023.1207385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436586/
https://www.ncbi.nlm.nih.gov/pubmed/37601046
http://dx.doi.org/10.3389/fphar.2023.1207385

Ejemplares similares